Drugs / BMS-986090
last change Apr 2016 re-read 2 minutes ago

BMS-986090

Investigated by
Bristol-Myers Squibb

Trials 1 · a red edge is where a trial was stopped

2015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 1 NCT02079480 May 2014 → Apr 2016 Bristol-Myers Squibb Terminated No outcome recorded

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as BMS-986090 ClinicalTrials.gov intervention name — accepted as the source's own label NCT02079480
Route Subcutaneous “single dose subcutaneously once” NCT02079480